Summit Therapeutics (SMMT)CEO bought ~$90K
Mahkam Zanganeh, CEO at Summit Therapeutics, bought ~$90K of Summit Therapeutics shares.
- ~$90K
- Approx. value · 5,000 sh @ $18.07
- 556M
- Holds after · shares reported
- Traded
- Sep 11, 2025
- Filed
- Sep 11, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Sep 10, 2025Insider · 2 peopleInsiders: 2 purchases (~$11.8M)
- Sep 11, 2025 · this disclosureInsiderCEO purchased ~$90K of SMMT shares in the open market
What came next
- Sep 11, 2025InsiderCEO purchased ~$90K of SMMT shares in the open market
- Oct 17, 2025Company filing · Form 8-K · Results, Other newsReported its results, and reported other company news
- Oct 21, 2025Company filing · Form 8-K · Material agreement, Unregistered sharesSigned an important agreement, and sold new shares without registering them (and 1 more item)
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Summit Therapeutics
For Summit Therapeutics, OQRO holds 1 fund holdings report (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its SMMT page.
Other recent filings by Mahkam Zanganeh, Co-Chief Executive Officer
The full history of Mahkam Zanganeh, Co-Chief Executive Officer is on the profile page.
How this filing works
Other disclosures at Summit Therapeutics
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRFeb 17, 2026
- SEC Form 4Sep 11, 2025
- SEC Form 4Sep 11, 2025
- SEC Form 4Sep 11, 2025
- SEC Form 13F-HRAug 15, 2025
Everything OQRO holds on this company is on its SMMT page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data